Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-29T08:33:27.132Z Has data issue: false hasContentIssue false

Leptospirosis in Ireland: annual incidence and exposures associated with infection

Published online by Cambridge University Press:  05 August 2013

P. GARVEY*
Affiliation:
Health Protection Surveillance Centre, HSE, Dublin, Ireland
J. CONNELL
Affiliation:
National Virus Reference Laboratory, University College Dublin, Belfield, Dublin, Ireland
D. O'FLANAGAN
Affiliation:
Health Protection Surveillance Centre, HSE, Dublin, Ireland
P. McKEOWN
Affiliation:
Health Protection Surveillance Centre, HSE, Dublin, Ireland
*
*Author for correspondence: Dr P. Garvey, Health Protection Surveillance Centre, 25–27 Middle Gardiner Street, Dublin 1, Ireland. (Email: patricia.garvey@hse.ie)
Rights & Permissions [Opens in a new window]

Summary

Human leptospirosis is found throughout the world, albeit with a higher incidence in tropical regions. In temperate regions it is associated with certain occupational and recreational activities. This paper reports both on the incidence of human leptospirosis in Ireland and on possible associated exposures, using leptospirosis case notification, enhanced surveillance, hospital discharge data and death registrations. Based on official notification data, there was a threefold increase in the reported incidence of leptospirosis in Ireland between 1995–1999 and 2004–2009, which appears partially to be due to improved reporting. The exposures most associated with infection were those involving contact with livestock or water-based recreational sports, in particular kayaking. Advice on prevention should continue to be targeted in the first instance at these groups. The variety of potential transmission routes reported should inform clinicians to consider leptospirosis in individuals with a compatible clinical profile who were not from occupational groups historically considered at risk.

Type
Original Papers
Copyright
Copyright © Cambridge University Press 2013 

INTRODUCTION

Human leptospirosis is uncommon in Ireland, occurring more commonly in tropical climates. Nevertheless, between 20 and 30 cases are notified annually, and key to devising and monitoring preventive strategies for Ireland is identification of persons at risk and behaviours associated with increased risk of infection. Maintenance hosts for leptospires include cattle, rats, pigs and dogs, and activities that have been associated elsewhere with human leptospirosis include farming, occupations that involve contact with wet rodent-infested environments, recreational activities such as water sports, and flooding [1Reference Zitek and Benes6]. Many countries have reported a change in leptospirosis epidemiology in recent years, with an increasing proportion of cases related to recreational rather than occupational exposures [Reference Christova, Tasseva and Manev7Reference Olszyna10].

While a few studies have reviewed the epidemiology of leptospirosis in Ireland, none has reported exposure categories associated with leptospirosis infection [Reference Hogan11, Reference Pate12]. The aim of this paper is to report on the current epidemiology of human leptospirosis in Ireland, focusing in particular on possible exposures associated with acquiring leptospirosis, and drawing on data from a variety of data sources, including disease notifications, enhanced surveillance data, hospital discharge data and death registrations.

MATERIALS AND METHODS

Leptospirosis is a notifiable disease in Ireland and as for all notifiable diseases, basic demographic data is reported routinely on all cases. The case definition in use between 2004 and 2009 [13] was based on the European Union (EU) case definition [14].

Irish case definition for leptospirosis (Leptospira sp.)

Clinical description

Clinical picture compatible with leptospirosis, characterized by fever, headache, chills, myalgia, conjunctival suffusion, and less frequently by meningitis, rash, jaundice or renal insufficiency.

Laboratory criteria for diagnosis

  • Isolation of Leptospira sp. from a clinical specimen.

  • Demonstration of a specific increase in Leptospira agglutination titre (⩾fourfold rise).

  • Demonstration of Leptospira in a clinical specimen by immunofluorescence.

  • Detection of Leptospira IgM antibody in serum.

Case classification

  • Possible: not applicable.

  • Probable: not applicable

  • Confirmed: a clinically compatible case that is laboratory confirmed.

Prior to 2004, there was no case definition in place in Ireland. Under the 2004 case definition, only laboratory-confirmed cases of leptospirosis were notifiable. Since 2000, enhanced data including details on possible source of infections and information on risk awareness were specifically sought by public health physicians. Basic notification data and enhanced data were maintained in the Computerized Infectious Disease Reporting (CIDR) database, a central national repository for all infectious disease notifications data in Ireland. The notification data used in this report were retrieved from CIDR (as of 20 January 2011) on notifications of leptospirosis between 1995 and 2009 inclusive, and enhanced data were retrieved at the same time for those notifications reported between 2000 and 2009.

Where information on the possible source of infection was reported, cases were categorized into one of the following classes: (i) occupational, e.g. farming, veterinary, waste/waste water management, fishing, abattoir worker, or any other occupation which involves potential exposure to cattle or rats or water which could have been contaminated by rats; (ii) recreational, e.g. caving, kayaking, swimming in a river, rowing, or travel to a tropical destination; (iii) residential, e.g. dog or other pet ownership, homelessness, working in yard/garden, exposure to flooding in or around the home, rodent sightings near home, living (but not working) on a farm; or (iv) accidental, e.g. accidental falls into water [Reference Christova, Tasseva and Manev7, Reference Jansen15].

Hospital in-patient data collated by the Hospital In-Patient Enquiry (HIPE) and National Perinatal Reporting System (NPRS) unit of the Economic and Social Research Institute (ESRI) was obtained through the Health Intelligence Ireland portal, and used solely as an independent source of information on the trend in leptospirosis incidence in Ireland. An update was published in the International Classification of Diseases (ICD) coding during the study period, and thus data presented includes discharges based on different codes depending on the period in question: discharges of ICD-9 code 100* for the period 1995–2004 and discharges of ICD-10 code A27* for the period 2005–2009 but there was no material difference between codes. Any discharge which included a diagnosis of leptospirosis was included regardless of whether it was reported as the patient's primary diagnosis or an additional diagnosis. A caveat about these data is that there is no formal definition for ICD codes and therefore it has been suggested that a discharge recorded as leptospirosis would not require laboratory diagnosis, and could be recorded as such based on clinical diagnosis and decision to treat.

Leptospirosis death registration data were obtained from the Irish Central Statistics Office (CSO).

While in theory any of four methods of laboratory confirmation included in the notification case definition were acceptable for laboratory diagnosis, in practice, where known, the only form of initial diagnosis reported was antibody detection. Serum samples reactive in leptospirosis IgM tests at the National Virus Reference Laboratory (NVRL) University College Dublin, Ireland and other diagnostic laboratories in Ireland are referred for a microscopic agglutination test (MAT) to the United Kingdom Leptospirosis Reference Unit in Hereford (LRU). Serogroup/serovar data reported here were obtained from the LRU for the period 2000–2009 in aggregate form.

Average annual incidence rates were expressed as notifications/discharges/deaths per million population using the average annual number of notifications/discharges/deaths and the total Irish population recorded in the census closest to the mid-point of the 5-year period, e.g. the population from the 2006 Irish census was used as the denominator in calculating the rates in the period 2005–2009.

The statistical significance of the difference in proportions was tested using the χ 2 test or Fisher's exact test, as appropriate, using Stata v. 11.1 (StataCorp., USA).

RESULTS

Incidence

Based on the notification data, there was a statistically significant difference (P < 0·0001) in the reported incidence of leptospirosis in Ireland between 1995 and 2009, rising from a mean incidence of 1·8 notifications/million per annum in the period 1995–1999 to a mean incidence of 5·2/million per annum in the period 2005–2009 (Fig. 1, Table 1). In contrast, the estimated crude incidence rate of leptospirosis based on hospitalizations remained largely unchanged (P = 0·472) in the same time period, ranging from 5·7/million in the period 2000–2004 to 6·6/million in the period 1995–1999 (Fig. 1, Table 1).

Fig. 1. Annual number of leptospirosis notifications and hospital discharges, Ireland 1995–2009. [Data source: Computerized Infectious Disease Reporting (CIDR), Hospital In-Patient Enquiry (HIPE) via Health Intelligence Ireland].

Table 1. Comparison of leptospirosis notification data (CIDR), hospital discharge data (HIPE), death registration (CSO) and confirmations at UK LRU, 1995–2009

CIDR, Computerized Infectious Disease Reporting; HIPE, Hospital In-Patient Enquiry system; CSO, Irish Central Statistics Office; LRU, Leptospirosis Reference Unit; CI, confidence interval; CFR, case-fatality rate.

Data sources: a CIDR; b HIPE; c CSO; d LRU, Hereford.

* Census 1996 used for period 1995–1999, Census 2002 for 2000–2004 and Census 2006 for 2005–2009.

It was postulated previously by Hogan et al. [Reference Hogan11] that the discrepancy between notification and HIPE data on leptospirosis in Ireland indicated that the disease was under-notified by as much as three-quarters in the period 1985–1996. That estimate was based on using the number of hospital discharges of leptospirosis reported under the HIPE reporting system as an indicator of the true number of cases.

Using a similar approach to Hogan et al. described above, it was estimated that completeness of notification had improved to 80% in the period 2005–2009 (Table 1) compared to only 26% notified in the period studied by Hogan et al. [Reference Hogan11]. It is possible therefore that the reported increase in notifications may at least in part be due to improved reporting.

Mortality

Between 1995 and 2009, there were seven deaths due to leptospirosis in Ireland (CSO), which represents an annual mortality rate of between 0·05 and 0·22/million and a case fatality rate (CFR) of between 0·9% and 3·4% (when hospital discharge data are used as denominator) (Table 1). These were significantly lower than the average annual mortality of 0·47/million (P < 0·0001) and CFR of 10% (P = 0·004) as calculated previously by Hogan et al. (using HIPE data as denominator) for the period 1985–1996 [Reference Hogan11].

Serovar distribution

Between 2000 and 2009, 150 leptospirosis cases from throughout Ireland were confirmed at the LRU. The predominant serogroups/serovars detected in cases during that time period were serogroup Icterohaemorrhagiae (n = 49, 33%) and serogroup Hardjo (n = 37, 25%) (Table 1). Other serogroups/serovars accounted for a further 5% of cases (n = 8), including serogroup Autumnalis (n = 3), and one each of serogroups Ballum, Pomona, Saxkoebing, Tarassovi and Mini. Serogroup/serovar was not determined for 56 (37%) cases.

Interestingly, between the period studied by Hogan et al. [Reference Hogan11] and 2000–2004, there was an increase in the proportion of cases for which a serovar was determined (80% in 2000–2004 vs. 56% during the Hogan et al. study period, P = 0·001) but there was a subsequent decrease again in the period 2005–2009 (50%, P < 0·0001).

Of the cases for which a serovar was determined, there was no significant difference in the proportion of cases caused by the main two serovars (P = 0·392 and 0·736) for the three periods (Table 1); however, there was a significant increase (P = 0·003) in the proportion of cases caused by ‘other serovars’ (8·5%) in the period 2000–2009 relative to the period studied by Hogan et al. (0%) [Reference Hogan11].

Potential source of infection

Enhanced surveillance was introduced in 2000, and all subsequent analyses apply only to notification data from that time onward. Information on the possible source of infection was reported for over three-quarters of cases notified between 2000 and 2009. These were reviewed and categorized (Table 2). High-risk occupational and recreational activities accounted for the majority (85%) of leptospirosis cases with reported exposure during the study period.

Table 2. Reported likely sources of infection for human leptospirosis cases in Ireland, 2000–2009

Data source: Computerized Infectious Disease Reporting.

Farm, fishery, forestry and veterinary workers accounted for almost three-quarters of all occupational cases. Of recreational cases, the largest subgroup were kayakers (57%), while exposure while engaged in open water swimming accounted for a further 16% of this group. Ten cases (20% of recreational cases) reported holidaying in a tropical destination. All ten cases occurred since 2005 suggesting that this is an emerging risk factor for leptospirosis in Ireland. This was the only exposure subcategory in which there was a statistically significant change in the proportion of cases between 2000–2004 and 2005–2009 (P = 0·033). The majority (9/10) of these reported travelling to a destination within South East Asia.

Overall, the reported risk factor involved exposure to a body of fresh water in 42 cases [28 kayakers, eight swimmers (includes triathletes), one fisherman, three accidental cases and two occupational cases acquired following participation in river rescue courses]. Of these 42 cases, the river Liffey was reported in 23 instances as a location to which cases had been exposed, while the river Boyne was named in seven instances. No other location was named more than once, although for 12 cases, the name of the body of water was not reported. (It should be noted that cases may report exposure to more than one body of water during their potential exposure period.) During the study time frame, two outbreaks were reported in the east of the country that were associated with kayaking on the river Liffey [Reference Boland3, Reference O'Meara and Fitzgerald4]. These outbreaks accounted between them for ten of the kayaking-related cases notified.

Characteristics of notified cases

Of cases notified in the period 2000–2009, the majority (94%) were male with an age range of 13–85 (median 38) years (Table 3). For all exposure categories, male cases predominated; however, recreational cases appeared to be younger than occupational or residential cases. There are eight public health administrative regions in Ireland, the Health Service Executive (HSE) areas. While the majority of occupational cases were reported from more rural parts of the country, the majority of recreational cases were reported from HSE East (Table 3), a region which has a higher proportion of urban dwellers.

Table 3. Characteristics of leptospirosis cases by exposure category, Ireland 2000–2009

HSE, Health Service Executive; CIDR, Computerized Infectious Disease Reporting.

Data source: CIDR.

Overall, cases were more commonly notified in the latter half of the year (Table 3). This was particularly so for recreational and residential cases, with season having less influence on the distribution of occupational cases.

With regard to knowledge of risk (available for 53% of cases), recreational and occupational cases reported the highest level of awareness with 77% and 57% reporting awareness of risk prior to illness, respectively (Table 3).

Based on the serovar data linked to notification and enhanced data on CIDR (Table 3), serovar was reported for only 19 (12·1%) cases in the period 2000–2009, although there was a significant improvement (P = 0·014) in the proportion of cases for which linked serovar data was available in the 2005–2009 period (18/110, 16·4%) relative to the period 2000–2004 (1/47, 2·1%). Albeit based on limited data, serovar Hardjo was more commonly associated with occupational cases, while serovar Icterohaemorrhagiae was more commonly associated with recreational and residential cases (Table 3).

DISCUSSION

Although substantially lower than the incidence in tropical regions, Ireland now has a considerably higher reported incidence of leptospirosis than many other temperate countries. In 2009 (the latest year for which comparative data are available across the EU), the incidence rate across the EU was 1·4/million inhabitants (range 0·0–7·3/million by country) [16], compared to 5·6/million in Ireland; only Romania and Malta reported higher incidence rates than Ireland that year [16]. Moreover, in the last 15 years, there have been seven deaths attributed to leptospirosis in Ireland, an estimated CFR of around 2%.

While from notification data it seems that the incidence has risen significantly in the last 15 years, comparison of the trend with an alternative data source suggested that the increase may at least in part in part due to improved reporting [possibly more latterly influenced by an amendment to the Irish Infectious Diseases Regulations 1981 (Infectious Diseases (Amendment) (No. 3) Regulations 2003, S.I. No. 707 of 2003)] which took effect on 1 January 2004 [17]. A key change effected by this legislation was the addition of laboratory directors to the list of notifiers; prior to this legislation, only clinicians had a legal obligation to notify cases of infectious disease.

The age and sex distribution of Irish notified cases was similar to that reported previously for Ireland and elsewhere [Reference Hogan11, Reference Pate12, Reference Jansen15, 16, Reference Thornley18]. This has been attributed to male predominance in the occupational and recreational groups most at risk of infection. The exposures most associated with infection were selected high-risk occupations, in particular, those who have contact with livestock, e.g. farmers/veterinary practitioners, and water-based recreational sports participants, in particular kayakers. An emerging risk factor in later years was holiday travel to a tropical destination.

In accordance with previous studies in Ireland [Reference Hogan11, Reference Mongan19], the predominant serovars in the period 2000–2009 were Icterohaemorrhagiae and Hardjo. Serogroup Icterohaemorrhagiae has been associated with a rat reservoir, while serogroup Hardjo has been associated with cattle. These two reservoirs are consistent with the exposures reported by cases, with occupational (largely farming-related cases) being associated in this study with serogroup Hardjo, and recreational cases (largely water sports-related cases) being more commonly associated with serogroup Icterohaemorrhagiae.

The number of cases reporting exposure to the river Liffey during their incubation period is noteworthy. The river Liffey is a lowland river on which Ireland's capital city is built, and may have a higher number of recreational users than other rivers due its proximity to a large urban population. It also plays host to at least three major sporting events each autumn: an open water swim; a triathlon; and an international kayaking marathon, some of which are accompanied by artificial flooding from an upstream dam.

A number of countries have reported a change in the epidemiology of leptospirosis from being a mainly occupational disease to being increasingly a recreational one, and changes in the predominant serovars over time [Reference Christova, Tasseva and Manev7, Reference Ciceroni9, Reference Olszyna10, Reference Thornley18, Reference Kariv20]. Exposures noted internationally include participation in water-based activities while travelling in tropical destinations [1, Reference Jansen15] and outbreaks have been reported associated with the Eco-challenge event in 2000 and other water-based adventure sports events [Reference Sejvar2, 21]. In tropical regions, flooding is a recognized factor preceding increases in cases, and was noted also in the Czech Republic after the flooding events of 1997 and 2002 when incidence rates of leptospirosis infection rose threefold, many of the cases reporting exposure to residual water or mud in cellars [Reference Zitek and Benes6]. Urban exposures such as working in a large urban market were identified in cases in Israel [Reference Kariv20], and in Germany, concerns have been expressed about companion animals as a source of infection for humans [Reference Jansen15]. The only significant change in exposure category identified in Ireland over the last 10 years has been exposure during travel to a tropical destination.

The CFR of leptospirosis infection has been reported to vary with age and serovar [Reference Hogan11, Reference Holk, Nielsen and Rønne22]. Both mortality and CFR decreased considerably in comparison to the period studied by Hogan et al. [Reference Hogan11]. The reasons for this are unclear. It does not appear to be associated with serovar. Alternative explanations could include improved or more timely identification and treatment of cases, improved notification of less severe cases or a change in the age distribution of cases.

One of the limitations of routine surveillance highlighted in Ireland is the paucity of serovar information integrated with the notification dataset. This has improved considerably between the period 2000–2004 and 2005–2009, and with the continued implementation of CIDR in Ireland, we anticipate that reporting of linked serovar information will further improve, permitting more accurate evaluation of the association of serovar with exposure and outcome data within a single dataset.

Second, while there appears to have been an increase (80·6%) in the proportion of cases for which a serogroup/serovar was determined in 2000–2004, it was notable that there was a subsequent decrease (50%) in the proportion of cases for which a serogroup/serovar was determined in 2005–2009 (LRU data). A contributory factor appears to be a reduction in the number of cases for which follow-up samples were received by the LRU for serogroup/serovar determination (W. J. Zochowski, personal communication). Ideally, follow-up specimens should be submitted for all leptospirosis cases. If those cases for which a serovar was determined had the serovar details included in the national dataset, this would add considerable value.

As only 63% of the cases in this study had MAT confirmation and serogroup determination, there exists the possibility that some had other clinically compatible diseases. Hantavirus is a rodent-borne disease which has a worldwide distribution. Although a small number of indigenous cases infected with Seoul hantavirus have been described in the neighbouring UK, associated with exposure to pet rats, wild rats and laboratory rats [Reference Jameson23Reference Shi, McCaughey and Elliott25], and there have been reports of hantavirus seropositivity in humans and rodents in Northern Ireland [Reference McKenna26, Reference McCaughey27], to date only one imported case of hantavirus infection in humans has been diagnosed in Ireland [Reference O'Hora and O'Sullivan28]. A study in 2009 in which 176 patients with evidence of either rural or rodent exposures, were investigated for hantavirus IgM and hantavirus IgG using EIA and immunofluoresence (Hantavirus IgM DxSelect and Hantavirus IgG DxSelect, Focus Diagnostics, USA) showed no serological evidence for acute or previous hantavirus infection (J. Connell, personal communication), providing evidence against a major role for hantavirus in Ireland. Nevertheless, as hantavirus disease is transmitted from rodents, the public health advice that minimizes contact with rodent excreta, should be effective in preventing the risk of both leptospirosis and hantavirus infection in humans.

A further potential limitation of the dataset is that details on potential exposure were not available for 37 (24%) cases. Cases not assigned to exposure categories had a higher median age and were more likely to be from non-HSE East (and possibly more rural) areas than categorized cases, suggesting that they are more likely to comprise occupational or residential cases than recreational cases. As several of the recreational cases were part of the two outbreaks [Reference Boland3, Reference O'Meara and Fitzgerald4], it is also possible that some were identified through active case-finding and are even more unrepresentative of all cases that occurred in the time period.

Regardless of the completeness of reporting or the limitations of the available data, it is evident that leptospirosis incidence in Ireland is highest in those who work in high-risk occupations and those who engage in freshwater-based recreational activities. Prevention advice should continue to be targeted in the first instance at these groups. While no denominator data is available to evaluate if the river Liffey poses a higher risk than other freshwater bodies, the high number of cases associated with this river suggests that its users should be particularly vigilant against infection, and that organizers of events on this river should continue to advise participants about the risks of leptospirosis associated with water-based recreational activities.

If the low level of awareness in those cases classified as residential is a reflection of the level of awareness in the general population about the risk of acquiring leptospirosis and other environmentally transmitted diseases, there may also be a need for general educational material regarding incidental environmental exposure.

Historically considered an occupational disease, the variety of possible transmission routes reported here and elsewhere serves as a reminder to clinicians of leptospirosis as a possible diagnosis when compatible symptoms are observed, not just for patients in the occupational groups historically considered at risk.

ACKNOWLEDGEMENTS

We acknowledge the cooperation of clinicians, laboratory directors, microbiologists, medical scientists, Specialists in Public Health Medicine, Senior Medical Officers, surveillance scientists, infection control nurses, and (Principal) Environmental Health Officers in providing the notification and enhanced dataset on which this report is primarily based. We are also grateful to the HIPE and NPRS unit of the ESRI and to Health Intelligence Ireland for access to hospital discharge data, to the Central Statistics Office for mortality data, and to W. J. Zochowski and M. F. Palmer, LRU, Hereford for serovar data.

This study received no specific grant from any funding agency, commercial or not-for-profit sectors.

DECLARATION OF INTEREST

None.

References

REFERENCES

1. Department for Environment, Food and Rural Affairs. UK Zoonoses Report, 2009 (http://archive.defra.gov.uk/foodfarm/farmanimal/diseases/atoz/zoonoses/documents/reports/zoonoses2009.pdf).Google Scholar
2. Sejvar, J, et al. Leptospirosis in ‘Eco-Challenge’ athletes, Malaysian Borneo, 2000. Emerging Infectious Diseases 2003 9: 702707.CrossRefGoogle ScholarPubMed
3. Boland, M, et al. A cluster of leptospirosis cases in canoeists following a competition on the River Liffey. Epidemiology and Infection 2004 132: 195200.CrossRefGoogle ScholarPubMed
4. O'Meara, M, Fitzgerald, M. A cluster of leptospirosis cases in canoeists on a Dublin river. Eurosurveillance 2004; 8: pii=2592.Google Scholar
5. Nardone, A, et al. Risk factors for leptospirosis in metropolitan France: results of a national case-control study, 1999–2000. Clinical Infectious Diseases 2004; 39: 751753.CrossRefGoogle ScholarPubMed
6. Zitek, K, Benes, C. Longitudinal epidemiology of leptospirosis in the Czech Republic (1963–2003). Epidemiologie Mikrobiologie Imunologie 2005; 54: 2126.Google ScholarPubMed
7. Christova, I, Tasseva, E, Manev, H. Human leptospirosis in Bulgaria, 1989–2001: epidemiological, clinical, and serological features. Scandinavian Journal of Infectious Diseases 2003; 35: 869872.CrossRefGoogle ScholarPubMed
8. Katz, AR, et al. Leptospirosis in Hawaii, 1974–1998: epidemiologic analysis of 353 laboratory-confirmed cases. American Journal of Tropical Medicine and Hygiene 2002; 66: 6170.CrossRefGoogle ScholarPubMed
9. Ciceroni, L, et al. Epidemiological trend of human leptospirosis in Italy between 1994 and 1996. European Journal of Epidemiology 2000; 16: 7986.CrossRefGoogle ScholarPubMed
10. Olszyna, DP, et al. Leptospirosis in the Netherlands, 1991–1995. Nederlands Tijdschrift voor Geneeskunde 1998; 142: 12701273.Google ScholarPubMed
11. Hogan, MC, et al. Leptospirosis in the Republic of Ireland: 1985 to 1996. Communicable Disease Report Review 1997; 7: R185189.Google ScholarPubMed
12. Pate, GE, et al. A review of the epidemiology of leptospirosis in the Republic of Ireland. Irish Medical Journal 2000; 93: 114117.Google ScholarPubMed
13. Health Protection Surveillance Centre. Case definitions for notifiable diseases, February 2004.Google Scholar
14. European Union. 2002. Commission decision of 19 March 2002 laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (notified under document number C(2002) 1043) (2002/253/EC) (http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:086:0044:0062:EN:PDF).Google Scholar
15. Jansen, A, et al. Leptospirosis in Germany, 1962–2003. Emerging Infectious Diseases 2005; 11: 10481054.CrossRefGoogle ScholarPubMed
16. European Centre for Disease Control and Prevention. 2011. Annual epidemiological report. Reporting on 2009 surveillance data and 2010 epidemic intelligence data (http://ecdc.europa.eu/en/publications/Publications/1111_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf).Google Scholar
17. Health Protection Surveillance Centre. Changes to notification of infectious diseases. Epi-Insight 2004; 5: 1.Google Scholar
18. Thornley, CN, et al. Changing epidemiology of human leptospirosis in New Zealand. Epidemiology and Infection 2002; 128: 2936.CrossRefGoogle ScholarPubMed
19. Mongan, C. Leptospirosis in Ireland. Epi-Insight 2001; 2: 23.Google Scholar
20. Kariv, R, et al. The changing epidemiology of leptospirosis in Israel. Emerging Infectious Diseases 2001 7: 990992.CrossRefGoogle ScholarPubMed
21. Centers for Disease Control and Prevention. Update: leptospirosis and unexplained acute febrile illness among athletes participating in triathlons – Illinois and Wisconsin, 1998. Morbidity and Mortality Weekly Report 1998; 47: 673676.Google Scholar
22. Holk, K, Nielsen, SV, Rønne, T. Human leptospirosis in Denmark 1970–1996: an epidemiological and clinical study. Scandinavian Journal of Infectious Diseases 2000; 32: 533538.Google ScholarPubMed
23. Jameson, LJ, et al. Pet rats as a source of hantavirus in England and Wales, 2013 Eurosurveillance 2013; 18(9): pii=20415.CrossRefGoogle ScholarPubMed
24. Jameson, LJ, et al. The continued emergence of hantaviruses: isolation of a Seoul virus implicated in human disease, United Kingdom, October 2012. Eurosurveillance 2013; 18(1): pii=20344.CrossRefGoogle ScholarPubMed
25. Shi, X, McCaughey, C, Elliott, RM. Genetic characterisation of a Hantavirus isolated from a laboratory-acquired infection. Journal Medical Virology 2003; 1: 105109.CrossRefGoogle Scholar
26. McKenna, P et al. Serological evidence of Hantavirus disease in Northern Ireland. Journal Medical Virology 1994; 1: 3338.CrossRefGoogle Scholar
27. McCaughey, C et al. Evidence of hantavirus in wild rodents in Northern Ireland. Epidemiology and Infection 1996; 117: 361365.CrossRefGoogle ScholarPubMed
28. O'Hora, A, O'Sullivan, P. Hantavirus – a visitor from the continent. Epi-Insight 2012; 13(8).Google Scholar
Figure 0

Fig. 1. Annual number of leptospirosis notifications and hospital discharges, Ireland 1995–2009. [Data source: Computerized Infectious Disease Reporting (CIDR), Hospital In-Patient Enquiry (HIPE) via Health Intelligence Ireland].

Figure 1

Table 1. Comparison of leptospirosis notification data (CIDR), hospital discharge data (HIPE), death registration (CSO) and confirmations at UK LRU, 1995–2009

Figure 2

Table 2. Reported likely sources of infection for human leptospirosis cases in Ireland, 2000–2009

Figure 3

Table 3. Characteristics of leptospirosis cases by exposure category, Ireland 2000–2009